Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
01 1Aarti Pharmalabs Limited
02 1Agno Pharma Jiangsu
03 1American Pacific Corporation
04 1Apicore Pharmaceuticals Private Limited
05 2Apothecon Pharmaceuticals Pvt Ltd
06 1Darmerica, LLC
07 1Hainan Poly Pharm. Co., Ltd.
08 1Hetero Labs Limited
09 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10 1MSN Laboratories Private Limited
11 1Medisca Inc.
12 2Professional Compounding Centers of America dba PCCA
13 1SHILPA PHARMA LIFESCIENCES LIMITED
14 1VALARY LAB PRIVATE LIMITED
15 1Zhejiang Hisun Pharmaceutical Co., Ltd.
01 2CYCLOPHOSPHAMIDE
02 12Cyclophosphamide
03 3Cyclophosphamide Monohydrate
01 3China
02 7India
03 4U.S.A
04 2United Kingdom
05 1Blank
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0921
Start Marketing Date : 2021-09-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57821-004
Start Marketing Date : 2020-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50683-0468
Start Marketing Date : 2017-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-318
Start Marketing Date : 2020-12-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14335-360
Start Marketing Date : 2022-07-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 57884-0022
Start Marketing Date : 2012-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0506
Start Marketing Date : 2014-08-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0053
Start Marketing Date : 2016-11-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0133
Start Marketing Date : 2021-06-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-4871
Start Marketing Date : 2015-04-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Cyclophosphamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclophosphamide, including repackagers and relabelers. The FDA regulates Cyclophosphamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclophosphamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyclophosphamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyclophosphamide supplier is an individual or a company that provides Cyclophosphamide active pharmaceutical ingredient (API) or Cyclophosphamide finished formulations upon request. The Cyclophosphamide suppliers may include Cyclophosphamide API manufacturers, exporters, distributors and traders.
click here to find a list of Cyclophosphamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyclophosphamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyclophosphamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyclophosphamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyclophosphamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyclophosphamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyclophosphamide suppliers with NDC on PharmaCompass.
We have 14 companies offering Cyclophosphamide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
